Endothelial Growth Factor B Endothelial Fatty Acid Transport: Role of Vascular

[1]  S. Stone-Elander,et al.  Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes , 2012, Nature.

[2]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[3]  Fan Zhang,et al.  Complicated life, complicated VEGF-B. , 2012, Trends in molecular medicine.

[4]  B. Spiegelman,et al.  A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.

[5]  S. Miura,et al.  Skeletal Muscle-Specific Expression of PGC-1α-b, an Exercise-Responsive Isoform, Increases Exercise Capacity and Peak Oxygen Uptake , 2011, PloS one.

[6]  Céline Martin,et al.  CD36 as a lipid sensor , 2011, Physiology & Behavior.

[7]  E. Keshet,et al.  Vascular endothelial growth factor and vascular homeostasis. , 2011, Proceedings of the American Thoracic Society.

[8]  W. Stremmel,et al.  FATP4 contributes as an enzyme to the basal and insulin-mediated fatty acid uptake of C₂C₁₂ muscle cells. , 2011, American journal of physiology. Endocrinology and metabolism.

[9]  R. Scarpulla,et al.  Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. , 2011, Biochimica et biophysica acta.

[10]  T. Kodama,et al.  Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. , 2011, Cell metabolism.

[11]  D. Petersen,et al.  The human fatty acid-binding protein family: Evolutionary divergences and functions , 2011, Human Genomics.

[12]  Oliver T. Bruns,et al.  Brown adipose tissue activity controls triglyceride clearance , 2011, Nature Medicine.

[13]  A. Kleinfeld,et al.  Fatty Acid (FFA) Transport in Cardiomyocytes Revealed by Imaging Unbound FFA Is Mediated by an FFA Pump Modulated by the CD36 Protein* , 2010, The Journal of Biological Chemistry.

[14]  P. Carmeliet,et al.  Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation , 2010, Circulation.

[15]  T. Olivecrona,et al.  Triglyceride lipases and atherosclerosis , 2010, Current opinion in lipidology.

[16]  C. Schmitz‐Peiffer.  Targeting Ceramide Synthesis to Reverse Insulin Resistance , 2010, Diabetes.

[17]  M. Kay,et al.  FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. , 2010, American journal of physiology. Endocrinology and metabolism.

[18]  D. Muoio.  Metabolism and vascular fatty acid transport. , 2010, The New England journal of medicine.

[19]  S. Young,et al.  GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. , 2010, Cell metabolism.

[20]  M. Nieuwdorp,et al.  The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. , 2010, Atherosclerosis.

[21]  L. Zentilin,et al.  Cardiomyocyte VEGFR‐1 activation by VEGF‐B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  S. Stone-Elander,et al.  Vascular endothelial growth factor B controls endothelial fatty acid uptake , 2010, Nature.

[23]  B. Spiegelman,et al.  Transcriptional control of brown fat development. , 2010, Cell metabolism.

[24]  M. Shibuya,et al.  The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice. , 2010, Cardiovascular research.

[25]  R. Schwenk,et al.  Fatty acid transport across the cell membrane: regulation by fatty acid transporters. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[26]  T. Ince,et al.  Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Fan Zhang,et al.  VEGF-B , 2009, Cell adhesion & migration.

[28]  K. Ballmer-Hofer,et al.  Structure and function of VEGF receptors , 2009, IUBMB life.

[29]  R. Zechner,et al.  Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome. , 2009, American journal of human genetics.

[30]  R. Schwenk,et al.  Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6 , 2009, FEBS letters.

[31]  R. Silverstein,et al.  CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior , 2009, Science Signaling.

[32]  J. Luiken.  Sarcolemmal fatty acid uptake vs. mitochondrial beta-oxidation as target to regress cardiac insulin resistance. , 2009, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[33]  K. Becker,et al.  VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis , 2009, Proceedings of the National Academy of Sciences.

[34]  J. Storch,et al.  Structural and functional analysis of fatty acid-binding proteins Published, JLR Papers in Press, November 17, 2008. , 2009, Journal of Lipid Research.

[35]  P. Carmeliet,et al.  Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent Mechanisms , 2009, Circulation.

[36]  Jiandie D. Lin,et al.  Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism , 2008, Proceedings of the National Academy of Sciences.

[37]  J. Plutzky,et al.  PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. , 2008, The Journal of clinical investigation.

[38]  Christian Fischer,et al.  FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? , 2008, Nature Reviews Cancer.

[39]  A. Chait,et al.  Vascular Inflammation, Insulin Resistance, and Reduced Nitric Oxide Production Precede the Onset of Peripheral Insulin Resistance , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[40]  Seppo Ylä-Herttuala,et al.  Overexpression of Vascular Endothelial Growth Factor-B in Mouse Heart Alters Cardiac Lipid Metabolism and Induces Myocardial Hypertrophy , 2008, Circulation research.

[41]  P. Black,et al.  Fatty acid transport and activation and the expression patterns of genes involved in fatty acid trafficking. , 2008, Archives of biochemistry and biophysics.

[42]  H. Augustin,et al.  Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-binding Domain of Neuropilin-1* , 2008, Journal of Biological Chemistry.

[43]  P. Carmeliet,et al.  Reevaluation of the Role of VEGF-B Suggests a Restricted Role in the Revascularization of the Ischemic Myocardium , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[44]  L. Orci,et al.  Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome , 2008, Proceedings of the National Academy of Sciences.

[45]  D. Cheresh,et al.  Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. , 2008, Blood.

[46]  B. Spiegelman,et al.  HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α , 2008, Nature.

[47]  J. Borén,et al.  SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity , 2007, Nature Cell Biology.

[48]  D. Maiguel,et al.  The Fatty Acid Transport Protein (FATP) Family: Very Long Chain Acyl-CoA Synthetases or Solute Carriers? , 2007, Journal of Molecular Neuroscience.

[49]  W. Stremmel,et al.  Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4 , 2006, Journal of Cell Science.

[50]  A. Stahl,et al.  Protein-mediated fatty acid uptake: novel insights from in vivo models. , 2006, Physiology.

[51]  K. Feingold,et al.  FATP1 Is an Insulin-Sensitive Fatty Acid Transporter Involved in Diet-Induced Obesity , 2006, Molecular and Cellular Biology.

[52]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[53]  R. Gimeno,et al.  GASTROENTEROLOGY 2006;130:1245–1258 BASIC–LIVER, PANCREAS, AND BILIARY TRACT Targeted Deletion of FATP5 Reveals Multiple Functions in Liver Metabolism: Alterations in Hepatic Lipid Homeostasis , 2022 .

[54]  H. Lodish,et al.  GASTROENTEROLOGY 2006;130:1259–1269 Mice Deleted for Fatty Acid Transport Protein 5 Have Defective Bile Acid Conjugation and Are Protected From Obesity , 2022 .

[55]  F. Peale,et al.  Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice. , 2006, Blood.

[56]  P. Chambon,et al.  Disturbed epidermal structure in mice with temporally controlled fatp4 deficiency. , 2005, The Journal of investigative dermatology.

[57]  A. Stahl,et al.  Triglyceride accumulation in injured renal tubular cells: alterations in both synthetic and catabolic pathways. , 2005, Kidney international.

[58]  M. Camps,et al.  Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells. , 2005, American journal of physiology. Cell physiology.

[59]  N. Davidson,et al.  CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. , 2005, The Journal of clinical investigation.

[60]  P. Watkins,et al.  Comparative Biochemical Studies of the Murine Fatty Acid Transport Proteins (FATP) Expressed in Yeast* , 2005, Journal of Biological Chemistry.

[61]  Thomas Hartung,et al.  CD36 is a sensor of diacylglycerides , 2005, Nature.

[62]  Keita Kono,et al.  Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. , 2005, Cell metabolism.

[63]  P. Watkins,et al.  Mouse Very Long-chain Acyl-CoA Synthetase 3/Fatty Acid Transport Protein 3 Catalyzes Fatty Acid Activation but Not Fatty Acid Transport in MA-10 Cells* , 2004, Journal of Biological Chemistry.

[64]  M. Shibuya,et al.  Differential activation of vascular genes by hypoxia in primary endothelial cells. , 2004, Experimental cell research.

[65]  P. Grimaldi,et al.  CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness. , 2004, Diabetes.

[66]  H. Lodish,et al.  Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. , 2004, The Journal of clinical investigation.

[67]  W. Stremmel,et al.  Role of FATP in parenchymal cell fatty acid uptake. , 2003, Biochimica et biophysica acta.

[68]  Ying Sun,et al.  Targeted Deletion of Fatty Acid Transport Protein-4 Results in Early Embryonic Lethality* , 2003, Journal of Biological Chemistry.

[69]  B. Teusink,et al.  CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300143-JLR200 , 2003, Journal of Lipid Research.

[70]  Marjan S. Bolouri,et al.  Integrated Analysis of Protein Composition, Tissue Diversity, and Gene Regulation in Mouse Mitochondria , 2003, Cell.

[71]  A. F. Stewart,et al.  Mice with targeted disruption of the fatty acid transport protein 4 (Fatp 4, Slc27a4) gene show features of lethal restrictive dermopathy , 2003, The Journal of cell biology.

[72]  S. Yamashita,et al.  Pathophysiology of human genetic CD36 deficiency. , 2003, Trends in cardiovascular medicine.

[73]  Ying Sun,et al.  Characterization of a Heart-specific Fatty Acid Transport Protein* , 2003, The Journal of Biological Chemistry.

[74]  Daniel R. Martin,et al.  Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[75]  D. Ory,et al.  Oligomerization of the Murine Fatty Acid Transport Protein 1* , 2003, The Journal of Biological Chemistry.

[76]  R. Parker,et al.  Role of the fatty acid binding protein mal1 in obesity and insulin resistance. , 2003, Diabetes.

[77]  G. J. van der Vusse,et al.  Critical steps in cellular fatty acid uptake and utilization , 2002, Molecular and Cellular Biochemistry.

[78]  F. Kamp,et al.  Mechanism of cellular uptake of long-chain fatty acids: Do we need cellular proteins? , 2002, Molecular and Cellular Biochemistry.

[79]  A. Bonen,et al.  Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. , 2002, The Journal of clinical investigation.

[80]  H. Lodish,et al.  Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. , 2002, Developmental cell.

[81]  J. Cechetto,et al.  Immunogold localization of mitochondrial aspartate aminotransferase in mitochondria and on the cell surface in normal rat tissues. , 2002, Histology and histopathology.

[82]  K. Alitalo,et al.  Vascular Endothelial Growth Factor-B–Deficient Mice Display an Atrial Conduction Defect , 2001, Circulation.

[83]  P. Herrero,et al.  A novel mouse model of lipotoxic cardiomyopathy. , 2001, The Journal of clinical investigation.

[84]  Xuri Li,et al.  Isoform-specific Expression of VEGF-B in Normal Tissues and Tumors , 2001, Growth factors.

[85]  R. Silverstein,et al.  Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice* , 2000, The Journal of Biological Chemistry.

[86]  B. Spiegelman,et al.  Peroxisome proliferator–activated receptor γ ligands and atherosclerosis: ending the heartache , 2000 .

[87]  S. Hazen,et al.  Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. , 2000, The Journal of clinical investigation.

[88]  G. Kay,et al.  Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. , 2000, Circulation research.

[89]  T. Yagi,et al.  A requirement for neuropilin-1 in embryonic vessel formation. , 1999, Development.

[90]  U. Hellman,et al.  Differential Binding of Vascular Endothelial Growth Factor B Splice and Proteolytic Isoforms to Neuropilin-1* , 1999, The Journal of Biological Chemistry.

[91]  R. Silverstein,et al.  A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.

[92]  J. Mcwhir,et al.  Requirement for the heart‐type fatty acid binding protein in cardiac fatty acid utilization , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[93]  K. Alitalo,et al.  Localization of VEGF‐B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[94]  M. Shibuya,et al.  Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[95]  T. Noda,et al.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[96]  H. Lodish,et al.  A family of fatty acid transporters conserved from mycobacterium to man. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[97]  M. Kodama,et al.  Hypertrophic cardiomyopathy with type I CD36 deficiency. , 1998, Japanese circulation journal.

[98]  N. Simionescu,et al.  Heart microvessels and aortic endothelial cells express the 15 kDa heart-type fatty acid-binding proteins. , 1998, European journal of cell biology.

[99]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[100]  D. Gómez-Coronado,et al.  Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. , 1998, Journal of lipid research.

[101]  J. Saurat,et al.  Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein. , 1997, Circulation research.

[102]  K. Alitalo,et al.  Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia , 1997, Oncogene.

[103]  E. Kraegen,et al.  Alterations in the Expression and Cellular Localization of Protein Kinase C Isozymes ε and θ Are Associated With Insulin Resistance in Skeletal Muscle of the High-Fat–Fed Rat , 1997, Diabetes.

[104]  Bruce M. Spiegelman,et al.  Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2, the Adipocyte Fatty Acid Binding Protein , 1996, Science.

[105]  J. Rossant,et al.  Regulation of flt‐1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[106]  K. Alitalo,et al.  Genomic Organization of the Mouse and Human Genes for Vascular Endothelial Growth Factor B (VEGF-B) and Characterization of a Second Splice Isoform* , 1996, The Journal of Biological Chemistry.

[107]  G. Breier,et al.  The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.

[108]  K. Alitalo,et al.  Vascular endothelial growth factor B, a novel growth factor for endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[109]  G. Breier,et al.  Coordinate expression of vascular endothelial growth factor receptor‐1 (fit‐1) and its ligand suggests a paracrine regulation of murine vascular development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[110]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[111]  H. Lodish,et al.  Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein , 1994, Cell.

[112]  T. Ono,et al.  Immunohistochemical distribution of heart‐type fatty acid‐binding protein immunoreactivity in normal human tissues and in acute myocardial infarct , 1993, The Journal of pathology.

[113]  S. Patel,et al.  Structural, functional, and antigenic differences between bovine heart endothelial CD36 and human platelet CD36. , 1990, The Journal of biological chemistry.

[114]  J. Barnwell,et al.  Isolation of the thrombospondin membrane receptor. , 1987, The Journal of clinical investigation.

[115]  A. Bonen,et al.  Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. , 2010, Physiological reviews.

[116]  H. H. Marti.  Angiogenesis--a self-adapting principle in hypoxia. , 2005, EXS.

[117]  R. Reneman,et al.  Transport of long-chain fatty acids across the muscular endothelium. , 1998, Advances in experimental medicine and biology.

[118]  R. Unger.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0870 Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome , 2022 .